Published in Blood Weekly, May 21st, 2009
"This multicenter prospective study evaluated the feasibility, safety, and efficacy of endovenous laser ablation to treat SSVs. Between January 2003 and January 2007, 204 patients (229 limbs) with CV D and incompetent SSVs (evaluated by the LEAP classification) who were eligible for surgery underwent consecutive laser ablation procedures. Many required....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.